PREGABALIN Mepha sol buvable 20 mg/ml 473 ml

7680660000010 CH-66000 N02BF02 01.07.1.
PREGABALIN Mepha sol buvable 20 mg/ml 473 ml
PREGABALIN Mepha sol buvable 20 mg/ml 473 ml
PREGABALIN Mepha sol buvable 20 mg/ml 473 ml
1 / 3
google

Details

Product number
6600001
CPT
-
Packaging group
473
Unit
ml
Composition
pregabalinum 20 mg, natrii dihydrogenophosphas anhydricus et dinatrii phosphas corresp. natrium 0.755 mg, sucralosum, aqua purificata, aromatica, propylis parahydroxybenzoas 0.16 mg, E 218 1.3 mg ad solutionem pro 1 ml.

Articles (1)

Pregabalin-Mepha 20 mg/mL, Lösung zum Einnehmen
Lösung
473
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/08/2025
Patient information leaflet
Français
19/08/2025
Patient information leaflet
Italien
19/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.755 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
0.16 MG Substance HBESI
(N/A)
1.3 MG Substance HBESI

Reimbursement information

Public price
CHF 69.45
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2016

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66000
Drug name
Pregabalin-Mepha, Lösung zum Einnehmen
Galenic form
LSOR
ATC Code
N02BF02
Authorization status
Z
Dispensation category
B
First authorization
30/12/2015
Authorization expiration date
31/12/9999
IT number
01.07.1.
Domain
Human medicine
Field of application
Antiepilepticum, neuropathische Schmerzen, generalisierte Angststörungen

Packaging details

Description (FR)
PREGABALIN Mepha sol buvable 20 mg/ml 473 ml
Description (DE)
PREGABALIN Mepha Lös zum Einnehmen 20 mg/ml 473 ml
Market launch
30/12/2015
Narcotic (BTM)
No

Original drug

Lyrica, Hartkapseln
CHF 32.05
View original